DO THE PRETRANSPLANT USE OF STATINS IN DONORS AND RECIPIENT REDUCE THE INCIDENCE OF PRIMARY GRAFT DYSFUNCTION (PGD) AFTER LUNG TRANSPLANTATION (LT)?
Irene Bello,Alberto Sandiumenge,Elisabeth Coll,Mercedes de la Torre,Victor Manuel Mora,Silvana Crowley,Laura Romero,Fernando Mosteiro,Marina Perez,Borja Suberviola,Juan Galan,Jose Maria Duenas,Aroa Gomez,Judit Sacanell,Leire Sanchez,Cristopher Mazo,Cristina Berastegui,Teresa Pont,Maria Deu TRANSPLANT INTERNATIONAL（2019）
AI 理解论文
溯源树
样例
